Research examining outcomes in ovarian cancer has evolved from concentrating on more traditional clinical end points to also emphasizing quality of life (QOL). Both disease- and treatment-related factors may result in QOL decrements. Thus, QOL represents an important consideration in ovarian cancer treatment decision-making. This chapter reviews the physical, psychological, and sexual concerns that may influence QOL, as well as advances in the measurement of patient-reported QOL in ovarian cancer. The chapter discusses QOL in the context of recent treatment advances and highlights the need for future randomized controlled trials to assess the effects of intervention trials on QOL.
|Original language||English (US)|
|Title of host publication||Advances in Diagnosis and Management of Ovarian Cancer|
|Number of pages||20|
|ISBN (Print)||1461482704, 9781461482703|
|State||Published - Jan 1 2014|
ASJC Scopus subject areas